MVA
MED icon

Mount Vernon Associates’s Medifast MED Stock Holding History

Mount Vernon Associates’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-44,500
Closed -$1.15M – 48
2013
Q2 		$1.15M Buy
+44,500
New +$1.17M 1.24% 34

Other funds holding MED

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return
GOFM
GGC Opportunity Fund Management San Francisco, California $526M AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Mount Vernon Associates's MED Position: Q3 2013 in Review

Mount Vernon Associates sold out of Medifast (MED) in Q3 2013, closing a stake of 44,500 shares — an estimated $1.15M sold.

Mount Vernon Associates first reported a position in MED in Q2 2013 and held it in 1 quarter. The position peaked at $1.15M in Q2 2013. 140 funds tracked by Wall St. Rank hold MED as of Q3 2013.

  • Mount Vernon Associates reported no remaining Medifast position as of Q3 2013 after selling out during the quarter.
  • Mount Vernon Associates sold 44,500 Medifast shares in Q3 2013, an estimated $1.15M.
  • Mount Vernon Associates first reported a position in Medifast in Q2 2013 and held it in 1 quarter.
  • Mount Vernon Associates's Medifast position peaked at $1.15M in Q2 2013.
  • 140 funds tracked by Wall St. Rank held Medifast as of Q3 2013.

Based on Mount Vernon Associates's 13F filing for Q3 2013, filed 29 Oct 2013.